Lucid Diligence Brief: Lilly to acquire Ajax Therapeutics
Lucid Diligence Brief: Lilly to acquire Ajax Therapeutics Professional…
AI in Healthcare and Digital Health Today—April 28, 2026
This week’s Artificial Intelligence and Digital Health update highlights…
Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML
Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML Professional…
Lucid Diligence Brief: Sun Pharma acquisition of Organon
Lucid Diligence Brief: Sun Pharma acquisition of Organon Professional audiences…
Lucid Diligence Brief: Regeneron Otarmeni FDA approval
Lucid Diligence Brief: Regeneron Otarmeni FDA approval Professional audiences…
Lucid Diligence Brief: Avalyn Pharma IPO
Lucid Diligence Brief: Avalyn Pharma IPO Professional audiences only. Not…
Lucid Diligence Brief: Viz.ai and Johnson & Johnson collaboration on AI-powered subdural hemorrhage care
Lucid Diligence Brief: Viz.ai and Johnson & Johnson collaboration on…
Lucid Diligence Brief: Merck × Google Cloud agentic AI partnership
Lucid Diligence Brief: Merck × Google Cloud agentic AI partnership Professional…
Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million financing
Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million…
Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash
Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash…
AI in Healthcare and Digital Health Today—April 20, 2026
This week’s Artificial Intelligence and Digital Health update highlights…
Lucid Diligence Brief: 10x Genomics launches Atera Platform
Lucid Diligence Brief: 10x Genomics launches Atera Platform Professional…


